Cargando…

Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic

Italy was one of the last European countries to introduce vaccination in pharmacies. The urgent need to extend the vaccination campaign against SARS-CoV-2 led to the approval of Law no. 178/2020. The Law allowed the administration of COVID-19 vaccines in Italian pharmacies by community pharmacists o...

Descripción completa

Detalles Bibliográficos
Autores principales: Baratta, Francesca, Enri, Lorenzo Ravetto, Brusa, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030261/
https://www.ncbi.nlm.nih.gov/pubmed/36966630
http://dx.doi.org/10.1016/j.healthpol.2023.104798
_version_ 1784910319920873472
author Baratta, Francesca
Enri, Lorenzo Ravetto
Brusa, Paola
author_facet Baratta, Francesca
Enri, Lorenzo Ravetto
Brusa, Paola
author_sort Baratta, Francesca
collection PubMed
description Italy was one of the last European countries to introduce vaccination in pharmacies. The urgent need to extend the vaccination campaign against SARS-CoV-2 led to the approval of Law no. 178/2020. The Law allowed the administration of COVID-19 vaccines in Italian pharmacies by community pharmacists on an experimental basis for the years 2021-2022. Stakeholders took contrasting positions on the idea of enabling pharmacist to vaccinate after proper training. Sometimes, controversy existed even within the same associations representing pharmacists. As observed in other countries, the medical profession in Italy also expressed its opposition to the idea of pharmacists as vaccinators, while the general public and pharmacy customers were generally in favour of the policy. Over two million doses of SARS-CoV-vaccines were administered in Italian pharmacies in less than one year after the introduction of the policy. Criticism and concerns raised during the debate about the introduction of vaccination in pharmacies has subsided. It is yet unclear whether vaccination in pharmacies will be prolonged after the pandemic and whether it will, in fact, be expanded to other vaccines. Potentially, this could contribute towards increasing immunisation rates, not only for COVID-19, but also for other vaccines.
format Online
Article
Text
id pubmed-10030261
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-100302612023-03-22 Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic Baratta, Francesca Enri, Lorenzo Ravetto Brusa, Paola Health Policy Health Reform Monitor Italy was one of the last European countries to introduce vaccination in pharmacies. The urgent need to extend the vaccination campaign against SARS-CoV-2 led to the approval of Law no. 178/2020. The Law allowed the administration of COVID-19 vaccines in Italian pharmacies by community pharmacists on an experimental basis for the years 2021-2022. Stakeholders took contrasting positions on the idea of enabling pharmacist to vaccinate after proper training. Sometimes, controversy existed even within the same associations representing pharmacists. As observed in other countries, the medical profession in Italy also expressed its opposition to the idea of pharmacists as vaccinators, while the general public and pharmacy customers were generally in favour of the policy. Over two million doses of SARS-CoV-vaccines were administered in Italian pharmacies in less than one year after the introduction of the policy. Criticism and concerns raised during the debate about the introduction of vaccination in pharmacies has subsided. It is yet unclear whether vaccination in pharmacies will be prolonged after the pandemic and whether it will, in fact, be expanded to other vaccines. Potentially, this could contribute towards increasing immunisation rates, not only for COVID-19, but also for other vaccines. The Author(s). Published by Elsevier B.V. 2023-05 2023-03-22 /pmc/articles/PMC10030261/ /pubmed/36966630 http://dx.doi.org/10.1016/j.healthpol.2023.104798 Text en © 2023 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Health Reform Monitor
Baratta, Francesca
Enri, Lorenzo Ravetto
Brusa, Paola
Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic
title Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic
title_full Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic
title_fullStr Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic
title_full_unstemmed Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic
title_short Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic
title_sort community pharmacists as vaccinators in the italian sars-cov-2 immunization campaign: implications beyond the pandemic
topic Health Reform Monitor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030261/
https://www.ncbi.nlm.nih.gov/pubmed/36966630
http://dx.doi.org/10.1016/j.healthpol.2023.104798
work_keys_str_mv AT barattafrancesca communitypharmacistsasvaccinatorsintheitaliansarscov2immunizationcampaignimplicationsbeyondthepandemic
AT enrilorenzoravetto communitypharmacistsasvaccinatorsintheitaliansarscov2immunizationcampaignimplicationsbeyondthepandemic
AT brusapaola communitypharmacistsasvaccinatorsintheitaliansarscov2immunizationcampaignimplicationsbeyondthepandemic